tiprankstipranks
Trending News
More News >
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID

Ovid Therapeutics (OVID) Similar Stocks

Compare
1,659 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ovid Therapeutics
$1.64
$99.70M
54.72%
9 Buy
0 Hold
0 Sell
Strong Buy
Opus Genetics
$2.36
$153.79M
-1.30
131.37%
9 Buy
0 Hold
0 Sell
Strong Buy
Zentalis Pharmaceuticals
$1.41
$101.15M
-0.67
-55.27%
4 Buy
2 Hold
0 Sell
Moderate Buy
Inhibikase Therapeutics
$1.52
$118.48M
-1.46
-52.47%
3 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$24.59
$107.90M
-0.90
149.64%
3 Buy
0 Hold
0 Sell
Strong Buy
Biomea Fusion
$1.52
$89.09M
-0.42
-75.00%
5 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OVID
Ovid Therapeutics
1.64
0.61
59.22%
IRD
Opus Genetics
2.36
1.34
131.37%
ZNTL
Zentalis Pharmaceuticals
1.40
-1.69
-54.69%
IKT
Inhibikase Therapeutics
1.54
-1.90
-55.23%
SRZN
Surrozen
24.59
14.74
149.64%
BMEA
Biomea Fusion
1.41
-4.23
-75.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts